chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Total numbness left side of body head to toes. Left arm weak; Left foot cold; torso front and back numb (worse after 2nd vaccine); face, scalp etc. Symptoms worsened after 2nd vaccine. Now at 6 weeks duration.
The next morning after I got the second dose of the vaccine, I felt incredibly ill. Stomach was aching to the point I thought I was going to throw up, my joints were aching to the point it hurt to move, my skin hurt so touch, and I had a slight quick fever. These symptoms lasted all day, but went away the day after (Wednesday 24, 2021).
This case was reported by a nurse via call center representative and described the occurrence of injection site numbness in a female patient who received FLUARIX QUADRIVALENT (batch number CS979, expiry date 14th June 2017). Concomitant products included LEVAQUIN. On an unknown date, the patient received FLUARIX QUADRIVALENT. On an unknown date, less than a year after receiving FLUARIX QUADRIVALENT, the patient experienced injection site numbness. On an unknown date, the outcome of the injection site numbness was unknown. It was unknown if the reporter considered the injection site numbness to be related to FLUZRIX QUADRIVALENT. Additional details were provided as follows: The age at vaccination was not reported. The patient had numbness on the same arm where the injection was given. It was not known in which arm the vaccine was received. No additional details were known. This patient was going to visit the nurse the next day after reporting date for an appointment and the nurse practitioner said she would have more details then. The nurse practitioner reported minimal details for 3 different patients. All had the shot administered somewhere else within the hospital system but mentioned the events to this healthcare provider. She did not administer the vaccine. It is not known if CS979 is the exact lot number of the administered vaccine but she assumed it might be since it was the lot she had. She was also in a hurry to speak with Medical Information (MI) and was quickly providing information and now allowing all questions to be asked. This case was 1 of the 3 cases reported by the same reporter.
Patient admitted to hospital with COVID-19 pneumonia; started on ABX, steroids, remdesivir, albuterol, baricitinib; and O2 supplementation; Patient's condition continued to decline and he was made comfort care; He died in the hospital.
I received the shot at 4:00 PM 3/26/2021.  I had much of the same flu like symptoms for the first 48 hours, but when I awoke the morning after the shot I had red, oddly patterned blood/blister/bruises down the back side of my buttocks and legs (predominately my left leg).  I forgot to mention when I added my first vaccine reaction; two things... I smelled a "hair burning smell" for the first 72 hours also a few of these described marks appeared on my right buttock (I just thought I ran into something).  I showed the issue to a few close relatives and moved through the flu like symptoms but felt it needed to be looked at so I went to the Urgent Care as soon as I could on Monday the  29th.  The doctor identified the markings as autoimmune vasculitis response to the vaccine.   He ordered tests to check on the function of my organs.
no reported side effects; the syringe attached to the pre-filled syringe and stored in the refrigerator for 4 days. Per caller, the syringe was attached to give to a patient and the patient decided not to get it so it was placed back in the refrigerator and was accidentally u; Information has been received from a nurse, referring to a 28 year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  The reporting nurse stated that on 21-DEC-2021, 1 dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot number reported as "T0136442" (administration route and anatomical location were not reported) was administered to a patient after it had the syringe attached to the pre-filled syringe and stored in the refrigerator for 4 days. It was reported that the syringe was attached to give to a patient and the patient decided not to get it so it was placed back in the refrigerator and was accidently used 4 days later on 25-DEC-2021. The reporting nurse stated they have checked on patient since receiving hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) vaccine and patient had no reported side effects.  Lot number T0136442 is an invalid lot number for [hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9). Lot number T0136442  does not match any Company product as confirmed by Lot Verification team.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 12-JAN-2017 at 13:32, the patient was vaccinated with an improperly stored VARIVAX (lot # M031969) for prophylaxis (expiration date, dose and route of administration were not reported). It was reported that the vaccine underwent previous temperature excursions, but the number of previous excursions, time frames and values of incorrect temperature were unknown. A digital data logger was used. No adverse effects were reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457.
Patient received vaccines on june 20 2005 through EIS, TD, MMR, HEPA, HEBB.  She had completed vaccines and was standing at corner when she collapsed and fell to floor having small seizure.  She recovered quickly and was seen by provider.
This spontaneous report as received from a nurse refers to unspecified patients. The patients medical history was not reported. On an unknown date the unspecified patients were vaccinated with doses of GARDASIL that were exposed to a supported temperature excursion on unspecified dates. No adverse experience has been observed or reported. No product quality complaint (PQC) was reported for GARDASIL. Follow up information has been received from a registered nurse. The reporter stated that on 13-AUG-2014 one of the patients was administered with GARDASIL, lot # J006850, expiration date: 31-MAR-2016. This is one of several reporters from the same source. Additional information has been requested.
sever itching in palms of my hands, then on top with small blisters .Large blisters on both feet the size of egg. dermatology perform biopsies
Five months post vaccination of second pfizer dose, The next morning after my vaccination every joint in my body except the ones associated with my feet and knees. I could not move my arms, hips, or other joints without severe pain. I had a followup with a doctor a week post symptoms. In the meantime I used ibuprofen for the pain management. I was in constant pain and it was always worse in the morning. Symptoms were still there and was sent to a rheumatologist however was given prednisone prior to meeting rheumatologist. The prednisone did help slightly. The rheumatologist did x-rays of shoulders and hips and found no arthritis. I was prescribed Hydroxychloroquine twice daily and since then I haven't had nearly any pain in comparison. Physical therapy regularly and symptoms have pretty much gone away.
I tested positive for COVID-19 on 1/27/23. I had a scratchy throat, congestion, cough, fever, and anorexia. I contacted my doctor and was prescribed 5 days worth of PAXLOVID. I started to feel better after day three. I took another COVID-19 test on 2/3/23 and it was negative. Then, on 2/12/23, I started having some congestion, so I took another test and tested positive for COVID-19 again. So, I had a rebound case. These symptoms only lasted for about 48 hours. I feel better now and haven't taken another test because I haven't had symptoms.
Dizziness- Vertigo -- Tinnitus -- Nystagmus.   Was only given a half dose as each year she gets sick. She got Nystagmus 14 hours later!  Says that around 3 am that next morning she woke up with dizziness. Dizziness came in waves with rapid eye movement. Says that since then she has had a sore throat, several cold sores and is feeling very fatigued contines to have dizziness with ringing in her right ear. Has history of previous reaction to flu shots, but none as severe or long lasting as this one. She had Sanofi Pasteur Lot # UH8899AA. prefilled syringe without preservative.
COVID Breakthrough  Pfizer Dose 1 3/3/21 (EN6204) Pfizer Dose 2 3/24/21 (EP6955) COVID Positive 8/29/21  8/29/21: Patient is a 79-year-old male with history of type 2 DM, hypertension and hypothyroidism is brought to ED by ambulance following episode of syncope.  Patient states that earlier in the evening he was sitting in the chair, and suddenly passed out and fell on the floor.  Is not sure if he hit his head, and he was told that he was unresponsive for about a minute.  Denies chest pain or shortness of breath or feeling dizzy or lightheaded or nausea or vomiting.  Complains of having chills since yesterday, has cough for the past 4 5 days with small amounts of sputum.  He is not sure about the color the sputum as he was swallowing the sputum.  Denies shortness of breath or chest pain.  Denies dysuria or hematuria.  No leg swelling or calf pain.  His grandson has some upper respiratory symptoms at home.  Patient is vaccinated against COVID-19,  Pfizer vaccine in May 2021.     In the ED, his temp was 100.3° F, was mildly tachycardic, CBC negative for leukocytosis.  Chest x-ray reported as bilateral infiltrates.  Lactic was 2.9.  Was given IV vancomycin and Zosyn and 1 L fluid bolus and repeat lactic acid was 1.6.  His pulse ox is 95% on room air.  COVID-19 rapid test is positive.  8/30/21: 79-year-old male with history of type 2 DM, hypertension and hypothyroidism is brought to ED by ambulance following episode of syncope.  Found to have orthostatic hypotension, most of his blood pressure medications were discontinued, was given IV fluids for hydration, his COVID-19 test came back positive with bilateral lung infiltrates however patient did not have any respiratory symptoms and did not have any complaints, did not have any fever, no cough or shortness of breath, no difficulty breathing, no sputum production, was saturating well on room air and ambulating hallways with no symptoms at all.  He was stable for discharge.
Light headed, dizzy, 5 minutes after vaccine. 124/84. Given bottled water, observed, felt better, released.
PATIENT RECEIVED VACCINE AT 5:45PM AND HAD NO ADVESRE EFFECTS AT 6:00PM, SO SHE WAS ALLOWED TO LEAVE. NO PRIOR HISTORY OF ALLERGIC REACTIONS.  CAME BACK TO THE PHARMACY AT 6:45PM COMPLAINING OF TINGLING IN THE SIDES OF HER FACE AND NECK AND THE TOP OF HER HEAD. ALSO COMPLAINED OF HIP PAIN. GAVE 50MG BENADRYL AND MONITORED PATIENT. AFTER 10 MINUTES SHE SAID IT WAS STARTING TO SUBSIDE AND SHE WAS FEELING BETTER.
medication error due to temperature excursion product administered to patient with no reported AE; medication error due to temperature excursion product administered to patient with no reported AE; Initial information received on 12-Oct-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-health care professional.  This case involves a 42 years old of an unknown gender patient who was administered vaccines post medication error due to temperature excursion with no reporter adverse event , after receiving vaccine INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 06-Oct-2022, the patient received a  dose of suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED( lot UJ899AA and expiration date:30-Jun-2023) at an unknown dose via unknown route in unknown administration site as prophylactic vaccination.  On 06-Oct-2022 ,the patient developed a non-serious  event of medication error due to temperature excursion product administered to patient with no reported ae (poor quality product administered) (latency: same day)(Product storage error )(Latency: Unknown).   Action taken :not applicable  It was not reported if the patient received a corrective treatment for the events.   Outcome: Unknown for both events   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This spontaneous report as received from a physician refers to several patients of unknown age. The patients were vaccinated with VARIVAX (Lot#, dose and route not reported) instead of ZOSTAVAX. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. It was not known if the patients sought for medical attention. Follow-up information has been received from the physician via telephone memo on 10-AUG-2012 concerning that 12 patients were administered VARIVAX (merck) instead of ZOSTAVAX. The physician did not want to provide any patient identifiers, but stated that the clinic was making follow-up calls at the time of reporting to 9 patients who would be vaccinated with ZOSTAVAX 2-3 weeks later. And this is one of the 9 patients. No further information is available. This is one of several reports received from the same source. Additional information is not expected.
Client received vaccine at 10:45 am. Started experiencing soreness and swelling in (R) deltoid area at 3:00pm same day. Started experiencing chills & sweating at 6-7 pm. Couldn't get warm. Swelling extended down (R) arm & below (R) breast, the next day. Wasn't able to use arm yesterday. Can raise arm to shoulder area today. Reports slight headache and body aches. 90 x 120 cm induration on (R) arm distal to injection site. Injection site looks clear.
This spontaneous report as received from a registered nurse refers to an unknown number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of (Merck) PROQUAD (route, dose and lot # not reported). The temperature excursion was found to be unsupported with in house stability data. No adverse symptoms were reported. This is one of several reports received from the same source. Additional information has been requested.
Pt recvd MMR vax on 23JAN92 & immed devel wheals & hives @ inject site which spread to involve erythema of lt upper arm, chest & neck; pt also devel hot 4-in induration;
This spontaneous report as received from nurse refers to a patient of unknown age. On 12-AUG-2014 the patient was vaccinated with ROTATEQ (lot # was not reported). The reported ROTATEQ was exposed to temperatures outside of the proper storage range. No adverse effect reported. Additional information has been requested.
Temp of 103 when picked up from daycare and through the night.  Very lethargic/tired.  Gave Tylenol every 4 hrs and still high temp 09/10/15.
Quadracel vaccine was inadvertently administered today (25 Apr 2019) to a 12 month old patient instead of Pentacel, no adverse event; Quadracel vaccine was inadvertently administered today (25 Apr 2019) to a 12 month old patient instead of Pentacel, no adverse event; Initial information received on 25-Apr-2019 regarding an unsolicited valid non-serious case received from a consumer (Office Staff).  This case involves a 12 months old female patient who was inadvertently administered DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] instead of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Patient received one other vaccination today, which was for hepatitis A.  On 25-Apr-2019, the patient received a 0.5 ml dose of QUADRACEL (lot number: C5497AA and expiry date: 17-Jul-20120) via unknown route in unknown administration site instead of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL].  Todays dose was the third dose in the DTaP series and the third dose in the IPV series  It was an actual medication error due to wrong vaccine administered and Product administered to patient of inappropriate age.   No adverse event was reported following vaccination.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Starting on 06/03/2022, I had diarrhea as bad as you can possibly imagine. I've been able to control it but went to see my PCP who referred me to a gastroenterologist who performed a colonoscopy but was unable to determine a cause. I am able to treat myself with Imodium but am still working with doctors to determine a cause in order to find the right course of treatment.
I received booster shot in right arm on 12/08/21. At approximately 3 a.m. I woke up with extremely painful nerve pain from my right foot too my groin and pain and swelling at injection site.. Lost the use of my right foot which was so swollen I haven't been able to wear a shoe or bear weight on it. I have been a walker ever since. Went to advanced urgent care on 12/10/21 to rule out blood clot which was negative. They prescribed 5 day regime of steroid pills. Helped a little with swelling. I still cannot put weight on my right foot as of today 12/24/2021 and the nerve throbbing is still ever present
Patient noted to have immediate irritability that lasted for 24 hours. She developed a rash after 5 days.
swelling in the face; short of breath for a week; This case was reported by a consumer and described the occurrence of shortness of breath in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced shortness of breath and facial swelling. On an unknown date, the outcome of the shortness of breath and facial swelling were recovered/resolved.   It was unknown if the reporter considered the shortness of breath and facial swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but captured as adult as per vaccine indication. When the patient received 1st shingles shot a month ago from the day of reporting, the patient had a shot of breath for a week or so and some swelling in the face. For tolerance in 2nd dose refer case US2021AMR035414.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR035414:Same reporter
After my J&J vaccine I went to the hospital because the back of my right knee became very swollen and very painful. I have a varicose vein in that same area and with the swollenness my vein got enhanced a lot and was protruding out.  I work as a waitress and stand on my feet all day long. I went to see my doctor who prescribed me today a compression sleeve for my right knee. As of today, the back of my right knee is still swollen and painful.
Patient got PNEUMOVAX 23 on 10/19/2018 in left arm. Patient's daughter called today (11/14/18) saying that patient has had increasing pain in left upper arm since day after the vaccination. Patient's daughter says it has gotten to the point where patient cannot even sleep on left side. Informed patient's daughter to take patient to quickcare if no relief. Advised ice/heat + OTC pain relievers in meantime. Will report to VAERS and let RXManager know. Also asked patient's daughter to update us with findings if/when patient goes to quickcare. Patient has no PCP at this time to report reaction to.
Patient found in pulseless arrest on stairwell of her apartment building on the night of 4/2/21.  Patient transported via ambulance to hospital where she passed away.